JDQ-443

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameJDQ-443
Drug Alias NameJDQ-443JDQ443
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12C inhibitors
TargetsKRAS G12C
Therapy Area/IndicationsBrain metastasesSolid tumoursSmall Cell Lung Carcinoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgChina Novartis Institutes For Biomedical Research Co Ltd
Inactive CompaniesMaastricht University Medical Center
Active IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[5] 
Inactive IndicationsBrain metastases

Other Information

ATC CodeN/A
Related LinksN/A